The Journal of Medical Sciences

Register      Login

VOLUME 6 , ISSUE 3 ( July-September, 2020 ) > List of Articles

Original Article

Suppression of Cortisol Levels by a Bolus Dose of Etomidate in Patients Undergoing Laparoscopic Cholecystectomy

S Charuvi, S Dwajani

Keywords : Cortisol levels, Etomidate, Laparoscopic cholecystectomy

Citation Information : Charuvi S, Dwajani S. Suppression of Cortisol Levels by a Bolus Dose of Etomidate in Patients Undergoing Laparoscopic Cholecystectomy. J Med Sci 2020; 6 (3):10.5005/jp-journals-10045-00157.

DOI: 10.5005/jp-journals-10045-00157

License: CC BY-NC 4.0

Published Online: 29-09-2021

Copyright Statement:  Copyright © 2020; The Author(s).


Aim and objective: The main purpose of the study was to determine the effect of a bolus dose of etomidate on serum cortisol levels in patients undergoing laparoscopic cholecystectomy. As there are a lot of controversies regarding this, detailed research was carried out to find answers regarding the question as to whether etomidate suppresses the cortisol levels or not. Materials and methods: In this prospective interventional study, 31 ASA physical status I and II patients undergoing laparoscopic cholecystectomy were enrolled. Pre-anesthetic medication consisted of the tab. diazepam 5 mg the previous night and tab. ranitidine 150 mg the previous night and the next day morning at 5 am with sips of water. The patient was then induced with 0.4 mg/kg of etomidate intravenously. Skeletal muscle relaxant vancuronium of 0.1 mg/kg was administered. Intubation was performed with an appropriate endotracheal tube. Anesthesia was maintained with N2O, O2, and isoflurane. After surgery, the patient was reversed using neostigmine and glycopyrrolate. The patient was extubated when awake and then shifted to the recovery room and after one hour to the postoperative ward. Three venous samples, 2 mL each were drawn from each patient. The first blood sample T1 was drawn at 9 am on the day of the surgery before the induction of etomidate, the second blood sample T2 was 1 hour after the induction of etomidate which coincided with pneumoperitoneum, and the third blood sample T3 was drawn at 9 am the following morning. After the blood samples were collected in the red top vacutainers, they were allowed to clot naturally for about 30 minutes at room temperature after which tubes were centrifuged for 15 minutes at 1,000, 2,000, and 3,000 rpm, respectively, for the first, second, and third samples. After the separation of the serum, they were stored at −80°C until analysis. Sample analysis for cortisol estimation was done using Cobas E-411 machine using the electrochemiluminescence method. The statistical analysis was applied to analyze the demographic data, Chi-square test for categorical variables. Analysis was done using RM-ANOVA and significance was set at p < 0.05. Results: The statistical analysis showed the above table shows that males showed mean cortisol values of 11.48 ± 2.05 at time T1 which was at baseline, 9.78 ± 1.72 at time T2 which was at pneumoperitoneum, and 5.038 ± 4.22 at time T3 which was at 24 hours. The female patients showed mean cortisol values of 13.407 ± 2.33 at T1, 11.47 ± 2.65 at T2, and 7.065 ± 5.41 at T3. The combined mean cortisol levels of the patients were: 12.291 ± 1.57, 10.49 ± 1.52, and 6.085 ± 3.36 at intervals of T1, T2, and T3, respectively. According to the Student's t-test, the cortisol levels show that the p value (0.11) between T1 vs T2 does not show any significance. The p value (0.001) of T1 vs T3 is extremely significant and shows cortisol suppression and helps in proving the objective of the study. The p value (0.02) of T2 vs T3 was significant and shows that the cortisol levels are suppressed. Conclusion: Hence, this study showed that the cortisol levels are suppressed by a bolus dose of etomidate in patients undergoing laparoscopic cholecystectomy. It was not related to any adverse outcome. The major advantage of etomidate over other available intravenous induction agents is attributed to the remarkable cardiovascular stability it offers in patients with cardiac disease. It provides a “stress-free” state, in children which is of importance in high-stress surgeries like the Intracardiac repair of Tetralogy of Fallot using Cardiopulmonary Bypass. Its use probably could be restricted to those situations where it offers a clinical advantage over other available drugs until the clinical relevance of the adrenal suppression effects of etomidate is fully known.

  1. Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000;85(1):109–117. DOI: 10.1093/bja/85.1.109.
  2. Duthie D, Fraser R, Nimmo W. Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth 1985;57(2):156–159. DOI: 10.1093/bja/57.2.156.
  3. Bergen JM. A review of etomidate for sapid sequence intubation in the emergency department. J Emerg Med 15(2):221. DOI: 10.1016/s0736-4679(96)00350-2.
  4. Joris JL, Chiche JD, Canivet JL, et al. Hemodynamic changes induced by laparoscopy and their endocrine correlates: effects of clonidine. J Am Coll Cardiol 1998;32(5):1389–1396. DOI: 10.1016/s0735-1097(98)00406-9.
  5. Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology 1984;61(6):647–651. DOI: 10.1097/00000542-198412000-00003.
  6. Ebert TJ, Muzi M, Berens R, et al. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology 1992;76(5):725–733. DOI: 10.1097/00000542-199205000-00010.
  7. Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1983;1(8336):1270. DOI: 10.1016/s0140-6736(83)92712-5.
  8. Owen H, Spence AA. Etomidate. Br J Anaesth 1984;56(6):555–557. DOI: 10.1093/bja/56.6.555.
  9. Allolio B, Dorr H, Stuttmann R. Effect of a single bolus dose of etomidate upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol (Oxf) 1985;22(3):281–286. DOI: 10.1111/j.1365-2265.1985.tb03241.x.
  10. Longnecker DE. Stress free. To be or not to be? Anesthesiology 1984;61(6):643–644. DOI: 10.1097/00000542-198412000-00001.
  11. Sunshine JE, Deem S, Weiss NS, et al. Etomidate, adrenal function, and mortality in critically ill patients. Respir Care 2013;58(4):639–646. DOI: 10.4187/respcare.01956.
  12. Mehta MP, Dillman JB, Sherman BM, et al. Etomidate anesthesia inhibits the cortisol response to surgical stress. Acta Anaesthesiolog Scandinav 1985;29(5):486–489. DOI: 10.1111/j.1399-6576.1985.tb02239.x.
  13. Reves JG, Berkowitz DE. Pharmacology of intravenous anesthetic drugs. In: Kaplan JA, ed. Cardiac anesthesia. Philadephia: Saunders; 1993. pp. 512–534.
  14. Moore RA, Allen MC, Wood PJ, et al. Perioperative endocrine effects of etomidate. Anaesthesia 1985;40(2):124–130. DOI: 10.1111/j.1365-2044.1985.tb10702.x.
  15. Sear JW, Allen MC, Gales M, et al. Suppression by etomidate of normal cortisol response to anaesthesia and surgery. Lancet 1983;322(8357):1028. DOI: 10.1016/s0140-6736(83)91013-9.
  16. Kenyon CJ, Young J, Gray CE, et al. Inhibition by etomidate of steroidogenesis in isolated bovine adrenal cells. J Clin Endocrinol Metabol 1984;58(5):947–949. DOI: 10.1210/jcem-58-5-947.
  17. Fragen RJ, Shanks CA, Molteni A, et al. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology 1984;61(6):652–656. DOI: 10.1097/00000542-198412000-00004.
  18. Crozier TA, Flamm C, Speer CP, et al. Effects of etomidate on the adrenocortical and metabolic adaptation of the neonate. Br J Anaesth 1993;70(1):47–53. DOI: 10.1093/bja/70.1.47.
  19. Morel J, Salard M, Castelain C, et al. Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized double-blinded study. Br J Anaesth 2011;107(4):503–509. DOI: 10.1093/bja/aer169.
  20. Pandey AK, Chauhan S, Makhija N, et al. The variation in plasma cortisol levels in response to anesthetic induction with etomidate or ketamine in children undergoing intracardiac repair of tetralogy of fallot on cardiopulmonary bypass. World J Cardiovas Surg 2012;02(02):17–20. DOI: 10.4236/wjcs.2012.22006.
  21. Wanscher M, Tonnesen E, Huttel M, et al. Etomidate infusion and adrenocortical function (a study in elective surgery). Acta Anaesthes Scand 1985;29(5):483–485. DOI: 10.1111/j.1399-6576.1985. tb02238.x.
  22. Mornet E, Dupont J, Vitek A, et al. Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J Biol Chem 1989;264(35):20961–20967. DOI: 10.1016/S0021-9258(19)30030-4.
  23. Diago MC, Amado JA, Otero M, et al. Anti-adrenal action of a subanaesthetic dose of etomidate. Anaesthesia 1988;43(8):644–645. DOI: 10.1111/j.1365-2044.1988.tb04148.x.
  24. Mohammad Z, Afessa B, Finkielman JD. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care 2006;10(4):R105. DOI: 10.1186/cc4979.
  25. Nooraei N, Fathi M, Edalat L, et al. Effect of vitamin C on serum cortisol after etomidate induction of anesthesia. J Cell Mol Anesth 2016;1(1):28–33.
  26. Karayiannakis AJ, Makri GG, Mantzioka A, et al. Systemic stress response after laparoscopic or open cholecystectomy: a randomized trial. Br J Surg 1997;84(4):467–471. DOI: 10.1046/j.1365-2168.1997.02622.x.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.